Intermittent hypoxia exacerbates pancreatic β-cell dysfunction in a mouse model of diabetes mellitus

Sleep

Volumn 36, Issue 12, 2013, Pages 1849-1858

  Sherwani, Shariq I ^a,b   Aldana, Carolyn ^a,b   Usmani, Saif ^a,b   Adin, Christopher ^c   Kotha, Sainath ^a,b   Khan, Mahmood ^a   Eubank, Timothy ^a,b   Scherer, Philipp E ^d   Parinandi, Narasimham ^a,b   Magalang, Ulysses J ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

cell function; Diabetes mellitus; Fatty acids; Intermittent hypoxia

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CASPASE 3; FATTY ACID; GLUCOSE; INSULIN; MONOUNSATURATED FATTY ACID; PALMITIC ACID; STEARIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; EX VIVO STUDY; FATTY ACID ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RELEASE; INTERMITTENT HYPOXIA; MALE; MOUSE; MOUSE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIMETRY; OXYGEN TENSION; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; STAINING; TISSUE LEVEL;

DIABETES MELLITUS; FATTY ACIDS; INTERMITTENT HYPOXIA; Β-CELL FUNCTION;

ANIMALS; ANOXIA; APOPTOSIS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FATTY ACIDS; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED STRAINS;

EID: 84889017630     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.3214     Document Type: Article

References (57)

1. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-6.
2. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160:521-30.
3. Punjabi NM, Beamer BA. Alterations in glucose disposal in sleepdisordered breathing. Am J Respir Crit Care Med 2009;179:235-40.
4. Seicean S, Kirchner HL, Gottlieb DJ, et al. Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care 2008;31:1001-6.
5. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994;79:1681-5.
6. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009;106:1538-44.
7. Xu J, Long YS, Gozal D, Epstein PN. Beta-cell death and proliferation after intermittent hypoxia: role of oxidative stress. Free Radic Biol Med 2009;46:783-90.
8. Yokoe T, Alonso LC, Romano LC, et al. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 2008;586:899-911.
9. Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell 2012;148:1160-71.
10. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.
11. Boffetta P, McLerran D, Chen Y, et al. Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900, 000 individuals in the Asia cohort consortium. PLoS One 2011;6:e19930.
12. Kim JH, Saxton AM. The TALLYHO mouse as a model of human type 2 diabetes. Methods Mol Biol 2012;933:75-87.
13. Kim JH, Stewart TP, Soltani-Bejnood M, et al. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice. J Endocrinol 2006;191:437-46.
14. Guo J, Hall KD. Predicting changes of body weight, body fat, energy expenditure and metabolic fuel selection in C57BL/6 mice. PLoS One 2011;6:e15961.
15. Jun J, Reinke C, Bedja D, et al. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2010;209:381-6.
16. Li J, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 2005;97:698-706.
17. Bruder ED, Lee PC, Raff H. Metabolic consequences of hypoxia from birth and dexamethasone treatment in the neonatal rat: comprehensive hepatic lipid and fatty acid profiling. Endocrinology 2004;145:5364-72.
18. Bruder ED, Lee PC, Raff H. Dexamethasone treatment in the newborn rat: fatty acid profiling of lung, brain, and serum lipids. J Appl Physiol 2005;98:981-90.
19. Bruder ED, Lee PC, Raff H. Lipid and fatty acid profiles in the brain, liver, and stomach contents of neonatal rats: effects of hypoxia. Am J Physiol Endocrinol Metab 2005;288:E314-20.
20. Morgan NG, Dhayal S, Diakogiannaki E, Welters HJ. The cytoprotective actions of long-chain mono-unsaturated fatty acids in pancreatic betacells. Biochem Soc Trans 2008;36:905-8.
21. Eitel K, Staiger H, Brendel MD, et al. Different role of saturated and unsaturated fatty acids in beta-cell apoptosis. Biochem Biophys Res Commun 2002;299:853-6.
22. Saitoh Y, Hongwei W, Ueno H, Mizuta M, Nakazato M. Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells. Diabetes Res Clin Pract 2010;90:54-9.
23. El-Assaad W, Buteau J, Peyot ML, et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 2003;144:4154-63.
24. Vikram DS, Zweier JL, Kuppusamy P. Methods for noninvasive imaging of tissue hypoxia. Antioxid Redox Signal 2007;9:1745-56.
25. Khan M, Kwiatkowski P, Rivera BK, Kuppusamy P. Oxygen and oxygenation in stem-cell therapy for myocardial infarction. Life Sci 2010;87:269-74.
26. Pandian RP, Parinandi NL, Ilangovan G, Zweier JL, Kuppusamy P. Novel particulate spin probe for targeted determination of oxygen in cells and tissues. Free Radic Biol Med 2003;35:1138-48.
27. Khan M, Mohan IK, Kutala VK, et al. Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation. Antioxid Redox Signal 2009;11:725-38.
28. Pitombo C, Araujo EP, De Souza CT, Pareja JC, Geloneze B, Velloso LA. Amelioration of diet-induced diabetes mellitus by removal of visceral fat. J Endocrinol 2006;191:699-706.
29. Eubank TD, Roberts RD, Khan M, et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res 2009;69:2133-40.
30. Grujic D, Susulic VS, Harper ME, et al. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonistinduced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem 1997;272:17686-93.
31. Asterholm IW, Mundy DI, Weng J, Anderson RG, Scherer PE. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab 2012;15:171-85.
32. Parinandi NL, Thompson EW, Schmid HH. Diabetic heart and kidney exhibit increased resistance to lipid peroxidation. Biochim Biophys Acta 1990;1047:63-9.
33. Parinandi NL, Weis BK, Natarajan V, Schmid HH. Peroxidative modification of phospholipids in myocardial membranes. Arch Biochem Biophys 1990;280:45-52.
34. Lepage G, Roy CC. Specific methylation of plasma nonesterified fatty acids in a one-step reaction. J Lipid Res 1988;29:227-35.
35. Kodavanti UP, Thomas R, Ledbetter AD, et al. Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ Health Perspect 2011;119:312-8.
36. Hinzey AH KM, Kotha SR, Sliman SM, Butler ESO, Shelton AB, Gurney TO, Parinandi NL. Choice of cyclodextrin for cellular cholesterol depletion for vascular endothelial cell lipid raft studies: Cell membrane alterations, cytoskeletal reorganization and cytotoxicity. Ind J Biochem Biophys 2012;49:329-41.
37. Zmuda EJ, Powell CA, Hai T. A method for murine islet isolation and subcapsular kidney transplantation. J Vis Exp 2011 Apr 13.
38. Zmuda EJ, Viapiano M, Grey ST, Hadley G, Garcia-Ocana A, Hai T. Deficiency of Atf3, an adaptive-response gene, protects islets and ameliorates inflammation in a syngeneic mouse transplantation model. Diabetologia;53:1438- 50.
39. Carlsson PO, Liss P, Andersson A, Jansson L. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 1998;47:1027-32.
40. Harper SL, Pitts VH, Granger DN, Kvietys PR. Pancreatic tissue oxygenation during secretory stimulation. Am J Physiol 1986;250:G316-22.
41. Polotsky VY, Li J, Punjabi NM, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003;552:253-64.
42. Fenik VB, Singletary T, Branconi JL, Davies RO, Kubin L. Glucoregulatory consequences and cardiorespiratory parameters in rats exposed to chronic-intermittent hypoxia: effects of the duration of exposure and losartan. Front Neurol 2012;3:51.
43. Kim JH, Sen S, Avery CS, et al. Genetic analysis of a new mouse model for non-insulin-dependent diabetes. Genomics 2001;74:273-86.
44. Bienvenu G, Seurin D, Le Bouc Y, Even P, Babajko S, Magnan C. Dysregulation of energy homeostasis in mice overexpressing insulinlike growth factor-binding protein 6 in the brain. Diabetologia 2005;48:1189-97.
45. Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J. Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 2008;295:E1323-32.
46. Paolisso G, Gambardella A, Amato L, et al. Opposite effects of shortand long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995;38:1295-9.
47. Busch AK, Gurisik E, Cordery DV, et al. Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis. Diabetes 2005;54:2917-24.
48. Cabassi A, Coghi P, Govoni P, et al. Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab 2005;90:2888-97.
49. Weber JM, Reidy SP. Extending food deprivation reverses the short-term lipolytic response to fasting: role of the triacylglycerol/fatty acid cycle. J Exp Biol 2012;215:1484-90.
50. Kaushal N, Ramesh V, Gozal D. Human apolipoprotein E4 targeted replacement in mice reveals increased susceptibility to sleep disruption and intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol 2012;303:R19-29.
51. Iiyori N, Alonso LC, Li J, et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007;175:851-7.
52. Reinke C, Bevans-Fonti S, Drager LF, Shin MK, Polotsky VY. Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol 2011;111:881-90.
53. Lee EJ, Woodske ME, Zou B, O'Donnell CP. Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. J Appl Physiol 2009;107:290-4.
54. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447-52.
55. Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med;181:507-13.
56. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling Jr. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007;62:969-74.
57. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011;365:2277-86.